REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,499,579 | -53.1% | 6,756,720 | +3.5% | 0.00% | -60.0% |
| Q2 2023 | $165,187,942 | -16.5% | 6,526,588 | +6.3% | 0.01% | -16.7% |
| Q1 2023 | $197,739,254 | +51.4% | 6,139,064 | -13.2% | 0.01% | +50.0% |
| Q4 2022 | $130,583,512 | -21.1% | 7,073,863 | +15.4% | 0.00% | -33.3% |
| Q3 2022 | $165,559,000 | +110.7% | 6,131,816 | +7.9% | 0.01% | +100.0% |
| Q2 2022 | $78,564,000 | -23.8% | 5,684,831 | +7.5% | 0.00% | 0.0% |
| Q1 2022 | $103,101,000 | +18.4% | 5,287,148 | -0.9% | 0.00% | +50.0% |
| Q4 2021 | $87,052,000 | -41.8% | 5,334,099 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $149,649,000 | -5.6% | 5,371,467 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $158,506,000 | +5.1% | 5,347,678 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $150,758,000 | +6.1% | 5,393,839 | +7.6% | 0.00% | -20.0% |
| Q4 2020 | $142,051,000 | +15.8% | 5,012,352 | +2.7% | 0.01% | 0.0% |
| Q3 2020 | $122,713,000 | +13.2% | 4,881,188 | +10.0% | 0.01% | +25.0% |
| Q2 2020 | $108,406,000 | +82.8% | 4,439,200 | +10.8% | 0.00% | +33.3% |
| Q1 2020 | $59,309,000 | -0.9% | 4,007,379 | +8.6% | 0.00% | +50.0% |
| Q4 2019 | $59,868,000 | +29.1% | 3,688,657 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $46,357,000 | +1.3% | 3,565,971 | +1.1% | 0.00% | 0.0% |
| Q2 2019 | $45,759,000 | -18.2% | 3,528,059 | -0.6% | 0.00% | 0.0% |
| Q1 2019 | $55,951,000 | -13.3% | 3,550,138 | +10.7% | 0.00% | -33.3% |
| Q4 2018 | $64,549,000 | -18.7% | 3,206,600 | +0.4% | 0.00% | 0.0% |
| Q3 2018 | $79,395,000 | -1.4% | 3,194,983 | +9.0% | 0.00% | -25.0% |
| Q2 2018 | $80,482,000 | +8.4% | 2,931,980 | +21.6% | 0.00% | 0.0% |
| Q1 2018 | $74,243,000 | -4.2% | 2,410,444 | +11.2% | 0.00% | 0.0% |
| Q4 2017 | $77,513,000 | +29.9% | 2,168,211 | +0.1% | 0.00% | +33.3% |
| Q3 2017 | $59,662,000 | +5.0% | 2,165,600 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $56,842,000 | +33.4% | 2,153,123 | +5.1% | 0.00% | +50.0% |
| Q1 2017 | $42,600,000 | +141900.0% | 2,048,054 | +145461.8% | 0.00% | – |
| Q4 2016 | $30,000 | +15.4% | 1,407 | -13.4% | 0.00% | – |
| Q3 2016 | $26,000 | 0.0% | 1,624 | -14.2% | 0.00% | – |
| Q2 2016 | $26,000 | +4.0% | 1,893 | +28.8% | 0.00% | – |
| Q1 2016 | $25,000 | +92.3% | 1,470 | +299.5% | 0.00% | – |
| Q4 2015 | $13,000 | +18.2% | 368 | 0.0% | 0.00% | – |
| Q3 2015 | $11,000 | -8.3% | 368 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | +140.0% | 368 | +38.9% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 265 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | +33.3% | 265 | +50.6% | 0.00% | – |
| Q3 2014 | $3,000 | -50.0% | 176 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |